BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those who ...
New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...
A deep learning model may be able to outperform ophthalmologists in predicting neovascular age-related macular degeneration (nAMD) recurrence. Recurrence of neovascular age-related macular ...
Please provide your email address to receive an email when new articles are posted on . Age-related macular degeneration (AMD) is the fourth most common cause of blindness globally and the leading ...
Although treatment with anti-VEGF agents has improved the outcomes for patients with AMD, it has also placed a large burden on ophthalmic providers. The current study found that the incidence of nAMD ...
Watch as renowned retina specialists David A. Eichenbaum, MD and Ferhina S. Ali, MD, MPH, FASRS delve into innovative strategies designed to reduce the treatment burden for patients with diabetic ...
Faricimab demonstrated short-term improvements in visual and anatomical outcomes for nAMD patients switching from other anti-VEGF therapies. The study showed reductions in central macular thickness, ...
More than twofold increased risk seen for nAMD development in unadjusted and adjusted models. HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback